Treatment of glioma stem cell-engrafted mice with allogeneic NK cells in combination with inhibitors of integrin or TGF-β signaling or with TGFBR2 gene-edited allogeneic NK cells prevented glioma-induced NK cell dysfunction and tumor growth73. The gene discussed is TGFB1; the disease is central nervous system cancer.